Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrate.
about
Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia APotential role of a new PEGylated recombinant factor VIII for hemophilia A.ITI choice for the optimal management of inhibitor patients - from a clinical and pharmacoeconomic perspective.Inhibitors in haemophilia: what have we learned from registries? A systematic review.US Guidelines for immune tolerance induction in patients with haemophilia a and inhibitors.Comorbidities and inhibitors in adult patients with haemophilia: issues, costs and management strategies.Long-term outcome of haemophilia A patients after successful immune tolerance induction therapy using a single plasma-derived FVIII/VWF product: the long-term ITI study.Factor VIII alloantibody inhibitors: cost analysis of immune tolerance induction vs. prophylaxis and on-demand with bypass treatment.An International Prophylaxis Study Group (IPSG) survey of prophylaxis in inhibitor positive children/adults with severe haemophilia.Adult haemophilia A patients with inhibitors: successful immune tolerance induction with a single FVIII/VWF product.First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study.
P2860
Q26738507-C36FD5AC-EBB8-46BC-AF3B-F6A91A6607AAQ26744309-8D178B10-4F2D-47E9-BC62-0446558DE5CFQ38224296-BB3812FF-90DE-4A1D-BD3F-46E19AC1F09EQ38244389-4862EEA0-DFC6-4B4F-8CF1-2082152B00CEQ38511360-3CA676C0-CC6C-4D4C-8AF9-936F6833CE7BQ38613927-05D5CE80-B120-4375-9F30-0DDC2E12E606Q39666092-0A9EA402-1974-49B7-90EF-11B79CDC7862Q45260428-2A35FFDD-B79A-47A1-9EDE-1C4777216EFAQ45867030-A15A37E8-61F1-48A1-85D0-C1EB3B13CCCBQ45869510-FA199B98-D728-4743-B7AA-218C58B89BBFQ45877949-DB038D9F-8C99-4FBE-A903-DD1F0D9D8E0A
P2860
Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrate.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Primary and rescue immune tole ...... sma-derived FVIII concentrate.
@en
Primary and rescue immune tole ...... sma-derived FVIII concentrate.
@nl
type
label
Primary and rescue immune tole ...... sma-derived FVIII concentrate.
@en
Primary and rescue immune tole ...... sma-derived FVIII concentrate.
@nl
prefLabel
Primary and rescue immune tole ...... sma-derived FVIII concentrate.
@en
Primary and rescue immune tole ...... sma-derived FVIII concentrate.
@nl
P2093
P2860
P356
P1433
P1476
Primary and rescue immune tole ...... asma-derived FVIII concentrate
@en
P2093
E Santagostino
J Oldenburg
L M Aledort
R Peiró-Jordán
P2860
P356
10.1111/HAE.12263
P577
2013-11-19T00:00:00Z